Coverage by Indication
Our Cancer Populations USA and Global Cancer Epidemiology Forecast report series are available as either off-the-shelf downloads via our client library or on-demand for all following list of indications.
For custom reports for any indication not listed below, please email us to discuss your requirements. To view a free sample report, please complete our request form.
Executive summaries of selected reports are available free to download for those indications listed below in bold text.
CNS, Respiratory and
Head & Neck
Our epidemiology coverage for CNS, respiratory and head and neck indications includes:
- Astrocytoma and glioblastoma
- Large-cell lung cancer
- Larynx cancer
- Lung adenocarcinoma
- Mesothelioma
- Non-small-cell lung cancer
- Non-squamous non-small-cell lung cancer
- Oropharyngeal squamous cell carcinoma
- Small-cell-lung cancer
- Squamous-cell carcinoma of the head and neck
- Squamous-cell carcinoma of the larynx
- Squamous-cell carcinoma of the oral cavity
- Squamous cell carcinoma of the pharynx and overlapping areas
- Squamous-cell lung cancer
Digestive & Endocrine
Our epidemiology coverage for digestive and endocrine indications includes:
- Adenocarcinoma of the oesophagus
- Biliary tract cancer
- Cholangiocarcinoma
- Colon cancer
- Colorectal cancer
- Oesophagal cancer
- Exocrine pancreatic cancer
- Gastric adenocarcinoma
- Gastroesophageal adenocarcinoma
- Gastroesophageal cancer
- Hepatocellular carcinoma
- Liver and biliary tract cancer
- Rectal cancer
- Differentiated thyroid cancer
- Neuroendocrine tumours
Reproductive and Genito-Urinary
Our epidemiology coverage for reproductive and genito-urinary indications includes:
- Bladder cancer
- Breast cancer (all subtypes)
- Cervical cancer
- Endometrial cancer
- HER2-positive breast cancer (HR-positive or negative)
- HR negative, HER2 positive breast cancer
- HR-positive breast cancer (HER2 positive or negative)
- HR-positive, HER2 negative breast cancer
- HR-positive, HER2 positive breast cancer
- Non-metastatic prostate cancer
- Non-muscle-invasive bladder cancer
- Ovarian cancer
- Prostate cancer
- Renal-cell carcinoma
- Squamous-cell carcinoma of the oesophagus
- Triple-negative breast cancer
Haematological and Lymphatic
Our epidemiology coverage for haematological and lymphatic indications includes the following:
- Acute lymphoblastic leukaemia
- Acute myeloid leukaemia
- Acute myeloid leukaemia and high-risk myelodysplastic syndromes
- B-cell non-Hodgkin’s lymphoma
- Chronic myeloid leukaemia
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- Hodgkin’s lymphoma
- Mantle-cell lymphoma
- Mucosa-associated lymphoid tissue lymphoma
- Multiple myeloma
- Myelodysplastic syndromes
- Myelofibrosis
- Non-Hodgkin’s lymphoma
- Small-cell B-cell lymphoma and B-cell chronic lymphocytic leukaemia
- T-cell non-Hodgkin’s lymphoma
Get in touch with any questions.
